CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Grant or award Chief Executive Officer acquired 872,769 shares (grant or award)
- 4 Grant or award Chief Medical Officer, EVP R&D acquired 1,161,938 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Former President and CEO gave up 14,250 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 8,548 shares (to pay taxes)
- 4 Shares withheld for taxes Former SVP, Gen. Counsel gave up 8,550 shares (to pay taxes)
- 4 Grant or award Director acquired 17,857 shares (grant or award)
- 4 Open-market sale Director sold 600,000 shares at an average $0.35 ($207,720)
- 4 Open-market sale Director sold 745,892 shares at an average $0.38 ($285,125)
- 4 Open-market sale Director sold 1,523,346 shares at an average $0.37 ($570,155)
- 4 Open-market sale Director sold 1,430,753 shares at an average $0.43 ($609,169)
- 4 Open-market sale Director sold 3,078,820 shares at an average $0.48 ($1,474,249)
- 4 Open-market sale Director sold 1,173,582 shares at an average $0.44 ($515,106)
- 4 Open-market sale Director sold 1,513,088 shares at an average $0.49 ($734,189)
- 4 Open-market sale Director sold 100,000 shares at $0.41 ($41,400)
- 4 Open-market sale Director sold 1,223,936 shares at an average $0.43 ($521,987)
- 4/A Open-market sale Director sold 188,322 shares at $0.55 ($103,050)
Page 15 of 29 · 564 filings